A randomized phase III study comparing 2-weekly docetaxel, cisplatin and 5-FU (bDCF) with cisplatin and 5-FU (CF) in patients with metastatic or recurrent esophageal cancer: JCOG1314 (MIRACLE).

被引：0

作者：

Tsushima, Takahiro ^{[1
]}

Hironaka, Shuichi ^{[2
]}

Tsubosa, Yasuhiro ^{[3
]}

Kato, Ken ^{[4
]}

Nomura, Motoo ^{[5
]}

Hara, Hiroki ^{[6
]}

Kitagawa, Yuko ^{[7
]}

Koyanagi, Kazuo ^{[8
]}

Kajiwara, Takeshi ^{[9
]}

Takegawa, Naoki ^{[10
]}

Matsubara, Hisahiro ^{[11
]}

Baba, Hideo ^{[12
]}

Morita, Masaru ^{[13
]}

Masuzawa, Toru ^{[14
]}

Hasegawa, Hiroko ^{[15
]}

Kojima, Takashi ^{[16
]}

Machida, Ryunosuke ^{[17
]}

Sasaki, Keita ^{[17
]}

Takeuchi, Hiroya ^{[18
]}

Kadowaki, Shigenori ^{[19
]}

机构：

[1] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan

[2] Kyorin Univ, Dept Med Oncol, Fac Med, Tokyo, Japan

[3] Shizuoka Canc Ctr, Div Esophageal Surg, Shizuoka, Japan

[4] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan

[5] Kyoto Univ Hosp, Dept Clin Oncol, Kyoto, Japan

[6] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan

[7] Keio Univ, Dept Surg, Sch Med, Tokyo, Japan

[8] Tokai Univ, Sch Med, Dept Surg Gastroenterol, Isehara, Kanagawa, Japan

[9] Natl Hosp Org Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan

[10] Hyogo Canc Ctr, Dept Gastroenterol Oncol, Akashi, Hyogo, Japan

[11] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan

[12] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto, Japan

[13] Natl Hosp Org Kyushu Canc Ctr, Dept Gastroenterol Surg, Fukuoka, Japan

[14] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan

[15] Natl Hosp Org Osaka Natl Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan

[16] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[17] JCOG Data Ctr, Natl Canc Ctr Hosp, Operat Off, Tokyo, Japan

[18] Hamamatsu Univ Sch Med, Dept Surg, Hamamatsu, Shizuoka, Japan

[19] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期

关键词：

261-492-3532-2370-7650-2700; 281-318-6655; 261-566-9718-9794; 283-424-6846-271; 261-492-199-2823; 283-424-3573; 283-2494-7461; 4; 3; 2; 193; 54; 62; 256; 14; 6;

D O I：

10.1200/JCO.2024.42.3_suppl.322

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：322 / 322

页数：1